Mailed Self-Collection Kits Increase Rates of Cervical Cancer Screening
By Lori Solomon HealthDay Reporter
WEDNESDAY, June 11, 2025 -- Mailed self-collection (SC) kits may increase participation in cervical cancer screening, according to a study published online June 6 in JAMA Internal Medicine.
Jane R. Montealegre, Ph.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues compared the effectiveness of mailed SC kits, with and without patient navigation, versus telephone reminders for increasing cervical cancer screening. The analysis included 2,474 individuals overdue for cervical cancer screening and randomly assigned to a telephone reminder (TR) for clinic-based screening (828 individuals), TR with mailed SC (828 individuals), or TR with mailed SC and patient navigation (818 individuals).
The researchers found that at six months, 17.4 percent in the TR group, 41.1 percent in the SC group, and 46.6 percent in the SC with patient navigation group participated in cervical cancer screening. Relative participation was 2.36 times higher for SC and 2.68 times higher for SC with patient navigation (screening difference of 23.7 percent for SC and 29.2 percent for SC with patient navigation compared with TR).
"The large increase in cervical cancer screening participation using SC compared to TR suggests that SC should be considered in safety-net settings with suboptimal cervical cancer screening coverage," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Study Compares Benefits, Harms of Treatments for Chronic Hives
WEDNESDAY, July 23, 2025 -- Omalizumab and remibrutinib may be the most effective treatments for reducing hives, itch, and swelling with chronic urticaria, according to a study...
USPSTF Guidelines of Little Value for Estimating Preeclampsia Risk in Those at Moderate Risk
WEDNESDAY, July 23, 2025 -- Moderate U.S. Preventive Services Task Force (USPSTF) preeclampsia risk factors have little value for estimating the risk for preeclampsia, according...
Endocrine Society, July 12-15
The annual meeting of the Endocrine Society (ENDO 2025) was held from July 12 to 15 in San Francisco, attracting more than 7,000 participants, including clinicians, academicians...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.